Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Psychiatry Reports
Metadata
Title
Mifepristone treatment for psychotic depression
Author
Joachim F. Hallmayer, MD
Publication date
01-06-2002
Publisher
Current Medicine Group
Published in
Current Psychiatry Reports / Issue 3/2002
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-002-0021-x

Other articles of this Issue 3/2002

Current Psychiatry Reports 3/2002 Go to the issue

OriginalPaper

The stress-vulnerability hypothesis in psychotic disorders: Focus on the stress response systems

OriginalPaper

Delirium: An important (but often unrecognized) clinical syndrome

News

Web alert

Clinical Trials Report

Ketoconazole treatment for depression

Clinical Trials Report

Selective serotonin reuptake inhibitors and the platelet aggregation

OriginalPaper

Cannabis and psychosis